Welcome to LookChem.com Sign In|Join Free

CAS

  • or

116313-85-0

Post Buying Request

116313-85-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

116313-85-0 Usage

Chemical Properties

Dark Yellow Solid

Uses

Different sources of media describe the Uses of 116313-85-0 differently. You can refer to the following data:
1. 3,4-Dihydroxy-5-nitrobenzaldehyde (Entacapone EP Impurity C) is an Entacapone (E558500) impurity.
2. Entacapone (E558500) impurity.

Check Digit Verification of cas no

The CAS Registry Mumber 116313-85-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,6,3,1 and 3 respectively; the second part has 2 digits, 8 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 116313-85:
(8*1)+(7*1)+(6*6)+(5*3)+(4*1)+(3*3)+(2*8)+(1*5)=100
100 % 10 = 0
So 116313-85-0 is a valid CAS Registry Number.
InChI:InChI=1/C7H5NO5/c9-3-4-1-5(8(12)13)7(11)6(10)2-4/h1-3,10-11H

116313-85-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name 3,4-Dihydroxy-5-nitrobenzaldehyde

1.2 Other means of identification

Product number -
Other names 3-Nitro-4,5-dihydroxybenzaldehyde

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:116313-85-0 SDS

116313-85-0Synthetic route

isonitrovanillin
6635-20-7

isonitrovanillin

3,4-dihydroxy-5-nitrobenzaldehyde
116313-85-0

3,4-dihydroxy-5-nitrobenzaldehyde

Conditions
ConditionsYield
With hydrogen bromide; acetic acid In water at 110℃; for 39h;100%
With pyridine; aluminium trichloride In chloroform for 24h; ether cleavage; Heating;98%
With hydrogen bromide; acetic acid In water for 8h; Heating;96%
vanillin
121-33-5

vanillin

3,4-dihydroxy-5-nitrobenzaldehyde
116313-85-0

3,4-dihydroxy-5-nitrobenzaldehyde

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: diethyl ether; mixture of gaseous nitrogen oxides
2: fuming hydrochloric acid / 140 °C
View Scheme
Multi-step reaction with 2 steps
1: nitric acid; acetic acid / 0 - 20 °C
2: hydrogen bromide / water / 4 h / Reflux
View Scheme
Multi-step reaction with 2 steps
1.1: acetic acid; nitric acid / water / 4 h / 15 - 30 °C
2.1: tetrabutylammomium bromide; aluminum (III) chloride / dichloromethane / 0.5 h / 0 - 10 °C / Reflux
2.2: 25 h / 0 - 10 °C / Reflux
View Scheme
isonitrovanillin
6635-20-7

isonitrovanillin

pyrographite
7440-44-0

pyrographite

3,4-dihydroxy-5-nitrobenzaldehyde
116313-85-0

3,4-dihydroxy-5-nitrobenzaldehyde

Conditions
ConditionsYield
With acetic acid In conc. hydrobromic acid; water5.66 kg (80%)
isovanillin
621-59-0

isovanillin

3,4-dihydroxy-5-nitrobenzaldehyde
116313-85-0

3,4-dihydroxy-5-nitrobenzaldehyde

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: nitric acid / acetic acid
2: aluminum (III) chloride; pyridine / chloroform / Reflux
View Scheme
3-hydroxy-4-methoxy-5-nitrobenzaldehyde
80547-69-9

3-hydroxy-4-methoxy-5-nitrobenzaldehyde

3,4-dihydroxy-5-nitrobenzaldehyde
116313-85-0

3,4-dihydroxy-5-nitrobenzaldehyde

Conditions
ConditionsYield
With pyridine; aluminum (III) chloride In chloroform Reflux;
N-(3-chlorophenyl)-2-cyanoacetamide
17722-12-2

N-(3-chlorophenyl)-2-cyanoacetamide

3,4-dihydroxy-5-nitrobenzaldehyde
116313-85-0

3,4-dihydroxy-5-nitrobenzaldehyde

C16H10ClN3O5
1150310-12-5

C16H10ClN3O5

Conditions
ConditionsYield
With piperidine; acetic acid In toluene Knoevenagel condensation; Reflux;98%
2-cyano-N-(4-methoxyphenyl)acetamide
5382-38-7

2-cyano-N-(4-methoxyphenyl)acetamide

3,4-dihydroxy-5-nitrobenzaldehyde
116313-85-0

3,4-dihydroxy-5-nitrobenzaldehyde

C17H13N3O6
1150310-11-4

C17H13N3O6

Conditions
ConditionsYield
With piperidine; acetic acid In toluene Knoevenagel condensation; Reflux;95%
3,4-dihydroxy-5-nitrobenzaldehyde
116313-85-0

3,4-dihydroxy-5-nitrobenzaldehyde

3,4-dihydroxy-5-nitrobenzoic acid
84211-30-3

3,4-dihydroxy-5-nitrobenzoic acid

Conditions
ConditionsYield
With sodium chlorite; sodium dihydrogenphosphate dihydrate In water; dimethyl sulfoxide at 50℃; for 16.8333h;94%
With xanthin for 20h; pH=7.4; Enzymatic reaction;
3,4-dihydroxy-5-nitrobenzaldehyde
116313-85-0

3,4-dihydroxy-5-nitrobenzaldehyde

benzyl bromide
100-39-0

benzyl bromide

3-benzyloxy-4-hydroxy-5-nitro-benzaldehyde
312327-13-2

3-benzyloxy-4-hydroxy-5-nitro-benzaldehyde

Conditions
ConditionsYield
In N,N-dimethyl-formamide at 140℃; for 48h; Alkylation;93%
With sodium hydride In N,N-dimethyl-formamide85%
Stage #1: 3,4-dihydroxy-5-nitrobenzaldehyde With sodium hydride In N,N-dimethyl-formamide; mineral oil at 0℃; Inert atmosphere;
Stage #2: benzyl bromide In N,N-dimethyl-formamide; mineral oil at 0℃; for 1h; Inert atmosphere;
Stage #3: With acetic acid In N,N-dimethyl-formamide; mineral oil at 20℃; Inert atmosphere;
81%
3,4-dihydroxy-5-nitrobenzaldehyde
116313-85-0

3,4-dihydroxy-5-nitrobenzaldehyde

2-cyano-N-[3-(2-cyanoacetylamino)propyl]acetamide
111233-69-3

2-cyano-N-[3-(2-cyanoacetylamino)propyl]acetamide

(E)-2-Cyano-N-{3-[(E)-2-cyano-3-(3,4-dihydroxy-5-nitro-phenyl)-acryloylamino]-propyl}-3-(3,4-dihydroxy-5-nitro-phenyl)-acrylamide

(E)-2-Cyano-N-{3-[(E)-2-cyano-3-(3,4-dihydroxy-5-nitro-phenyl)-acryloylamino]-propyl}-3-(3,4-dihydroxy-5-nitro-phenyl)-acrylamide

Conditions
ConditionsYield
With 3-amino propanoic acid In ethanol for 4.5h; Heating;92%
2-cyano-N-m-tolylacetamide
54153-19-4

2-cyano-N-m-tolylacetamide

3,4-dihydroxy-5-nitrobenzaldehyde
116313-85-0

3,4-dihydroxy-5-nitrobenzaldehyde

C17H13N3O5
1150310-10-3

C17H13N3O5

Conditions
ConditionsYield
With piperidine; acetic acid In toluene Knoevenagel condensation; Reflux;89%
2-(pyrimidin-4-yl)acetonitrile
794522-90-0

2-(pyrimidin-4-yl)acetonitrile

3,4-dihydroxy-5-nitrobenzaldehyde
116313-85-0

3,4-dihydroxy-5-nitrobenzaldehyde

3-(3,4-dihydroxy-5-nitrophenyl)-2-(pyrimidin-4-yl)acrylonitrile

3-(3,4-dihydroxy-5-nitrophenyl)-2-(pyrimidin-4-yl)acrylonitrile

Conditions
ConditionsYield
With ammonium acetate In methanol at 80℃; for 4h;89%
3-(N,N-diphenylamino)-3-oxopropanenitrile
51838-06-3

3-(N,N-diphenylamino)-3-oxopropanenitrile

3,4-dihydroxy-5-nitrobenzaldehyde
116313-85-0

3,4-dihydroxy-5-nitrobenzaldehyde

C22H15N3O5
1150310-09-0

C22H15N3O5

Conditions
ConditionsYield
With piperidine; acetic acid In toluene Knoevenagel condensation; Reflux;88%
2-(pyrimidin-2-yl)acetonitrile
59566-45-9

2-(pyrimidin-2-yl)acetonitrile

3,4-dihydroxy-5-nitrobenzaldehyde
116313-85-0

3,4-dihydroxy-5-nitrobenzaldehyde

(E)-3-(3,4-dihydroxy-5-nitrophenyl)-2-(pyrimidin-2-yl)acrylonitrile

(E)-3-(3,4-dihydroxy-5-nitrophenyl)-2-(pyrimidin-2-yl)acrylonitrile

Conditions
ConditionsYield
With ammonium acetate In methanol for 5h; Reflux;88%
3,4-dihydroxy-5-nitrobenzaldehyde
116313-85-0

3,4-dihydroxy-5-nitrobenzaldehyde

ethylene dibromide
106-93-4

ethylene dibromide

8-nitro-2,3-dihydro-benzo[1,4]dioxine-6-carbonitrilebenzonitrile
698986-32-2

8-nitro-2,3-dihydro-benzo[1,4]dioxine-6-carbonitrilebenzonitrile

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 80℃; for 5h;87%
5-chlorobenzofuran-3(2H)-one
3261-05-0

5-chlorobenzofuran-3(2H)-one

3,4-dihydroxy-5-nitrobenzaldehyde
116313-85-0

3,4-dihydroxy-5-nitrobenzaldehyde

(2Z)-5-chloro-2-[(3,4-dihydroxy-5-nitrophenyl)methylidene]benzofuran-3-one

(2Z)-5-chloro-2-[(3,4-dihydroxy-5-nitrophenyl)methylidene]benzofuran-3-one

Conditions
ConditionsYield
With hydrogenchloride In water; isopropyl alcohol at 80℃;86%
malonic acid
141-82-2

malonic acid

3,4-dihydroxy-5-nitrobenzaldehyde
116313-85-0

3,4-dihydroxy-5-nitrobenzaldehyde

(E)-3-(3,4-dihydroxy-5-nitrophenyl)acrylic acid

(E)-3-(3,4-dihydroxy-5-nitrophenyl)acrylic acid

Conditions
ConditionsYield
With pyridine; aniline In toluene for 2h; Reflux;84.6%
With piperidine; pyridine at 60℃; for 48h; Knoevenagel Condensation;40%
piperidine
110-89-4

piperidine

2-cyano-N,N-diethylacetamide
26391-06-0

2-cyano-N,N-diethylacetamide

3,4-dihydroxy-5-nitrobenzaldehyde
116313-85-0

3,4-dihydroxy-5-nitrobenzaldehyde

entacapone; piperidine salt
1047659-01-7

entacapone; piperidine salt

Conditions
ConditionsYield
With acetic acid In isopropyl alcohol for 3h; Product distribution / selectivity; Heating / reflux;79.7%
4-cyanoacetylmorpholine
15029-32-0

4-cyanoacetylmorpholine

3,4-dihydroxy-5-nitrobenzaldehyde
116313-85-0

3,4-dihydroxy-5-nitrobenzaldehyde

C14H13N3O6
1150310-16-9

C14H13N3O6

Conditions
ConditionsYield
With piperidine; acetic acid In toluene Knoevenagel condensation; Reflux;78%
With ammonium acetate In methanol for 5h; Reflux;19%
3,4-dihydroxy-5-nitrobenzaldehyde
116313-85-0

3,4-dihydroxy-5-nitrobenzaldehyde

cyclopentanone
120-92-3

cyclopentanone

2,5-bis(3,4-dihydroxy-5-nitrobenzylidene)cyclopentanone
116313-82-7

2,5-bis(3,4-dihydroxy-5-nitrobenzylidene)cyclopentanone

Conditions
ConditionsYield
With hydrogenchloride In methanol at 5℃;77%
4.4 g (78%)
3-(3-methoxyisoxazol-5-yl)-3-oxopropanenitrile

3-(3-methoxyisoxazol-5-yl)-3-oxopropanenitrile

3,4-dihydroxy-5-nitrobenzaldehyde
116313-85-0

3,4-dihydroxy-5-nitrobenzaldehyde

(E)-3-(3,4-dihydroxy-5-nitrophenyl)-2-(3-methoxyisoxazole-5-carbonyl)acrylonitrile

(E)-3-(3,4-dihydroxy-5-nitrophenyl)-2-(3-methoxyisoxazole-5-carbonyl)acrylonitrile

Conditions
ConditionsYield
With ammonium acetate In methanol for 3h; Reflux;76%
2-cyano-N,N-diethylacetamide
26391-06-0

2-cyano-N,N-diethylacetamide

3,4-dihydroxy-5-nitrobenzaldehyde
116313-85-0

3,4-dihydroxy-5-nitrobenzaldehyde

entacapone
130929-57-6

entacapone

Conditions
ConditionsYield
Stage #1: 2-cyano-N,N-diethylacetamide; 3,4-dihydroxy-5-nitrobenzaldehyde With piperidine In 1,2-dimethoxyethane; n-heptane for 15 - 25h; Heating / reflux;
Stage #2: In dichloromethane at 25 - 35℃; for 24h; Product distribution / selectivity;
75%
With piperidine In isopropyl alcohol for 12 - 15h; Heating / reflux;75.5%
Stage #1: 2-cyano-N,N-diethylacetamide; 3,4-dihydroxy-5-nitrobenzaldehyde With acetic acid; diethylamine In toluene Knoevenagel Condensation;
Stage #2: With hydrogen bromide In acetic acid; toluene at 20℃;
73.8%
2-cyano-N,N-diethylacetamide
26391-06-0

2-cyano-N,N-diethylacetamide

3,4-dihydroxy-5-nitrobenzaldehyde
116313-85-0

3,4-dihydroxy-5-nitrobenzaldehyde

A

entacapone
130929-57-6

entacapone

B

(2Z)-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethyl-2-propenamide
145195-63-7

(2Z)-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethyl-2-propenamide

Conditions
ConditionsYield
Stage #1: 2-cyano-N,N-diethylacetamide; 3,4-dihydroxy-5-nitrobenzaldehyde With piperidine In isopropyl alcohol for 12 - 15h; Heating / reflux;
Stage #2: With acetic acid In isopropyl alcohol at 20℃;
A 75.5%
B n/a
piperidine; methylamine hydrochloride In butan-1-ol at 82℃; for 4 - 5h; Product distribution / selectivity;
piperidine; methylamine hydrochloride In i-Amyl alcohol at 89 - 90℃; for 3h; Product distribution / selectivity;
3,4-dihydroxy-5-nitrobenzaldehyde
116313-85-0

3,4-dihydroxy-5-nitrobenzaldehyde

6-nitrobenzene-1,2,4-triol

6-nitrobenzene-1,2,4-triol

Conditions
ConditionsYield
With dihydrogen peroxide; sodium hydroxide In methanol; water at 60℃; for 3h;75%
3,4-dihydroxy-5-nitrobenzaldehyde
116313-85-0

3,4-dihydroxy-5-nitrobenzaldehyde

2-(pyridazin-3-yl)acetonitrile
27349-80-0

2-(pyridazin-3-yl)acetonitrile

(E)-3-(3,4-dihydroxy-5-nitrophenyl)-2-(pyridazin-3-yl)acrylonitrile

(E)-3-(3,4-dihydroxy-5-nitrophenyl)-2-(pyridazin-3-yl)acrylonitrile

Conditions
ConditionsYield
With ammonium acetate In methanol at 80℃; for 4h;75%
3,4-dihydroxy-5-nitrobenzaldehyde
116313-85-0

3,4-dihydroxy-5-nitrobenzaldehyde

diethyl malonate
105-53-3

diethyl malonate

diethyl 2-(3,4-dihydroxy-5-nitrobenzylidene)malonate

diethyl 2-(3,4-dihydroxy-5-nitrobenzylidene)malonate

Conditions
ConditionsYield
With piperidine; pyridine at 60℃; for 7h; Knoevenagel Condensation;69.01%
2-(1,2,4-thiadiazol-5-yl)acetonitrile

2-(1,2,4-thiadiazol-5-yl)acetonitrile

3,4-dihydroxy-5-nitrobenzaldehyde
116313-85-0

3,4-dihydroxy-5-nitrobenzaldehyde

(E)-3-(3,4-dihydroxy-5-nitrophenyl)-2-(1,2,4-thiadiazol-5-yl)acrylonitrile

(E)-3-(3,4-dihydroxy-5-nitrophenyl)-2-(1,2,4-thiadiazol-5-yl)acrylonitrile

Conditions
ConditionsYield
With ammonium acetate In methanol for 5h; Reflux;69%
3,4-dihydroxy-5-nitrobenzaldehyde
116313-85-0

3,4-dihydroxy-5-nitrobenzaldehyde

acetophenone
98-86-2

acetophenone

3-(3,4-dihydroxy-5-nitrophenyl)-1-phenylprop-2-en-1-one
116313-76-9

3-(3,4-dihydroxy-5-nitrophenyl)-1-phenylprop-2-en-1-one

Conditions
ConditionsYield
With hydrogenchloride In methanol68%
hydrogen ethyl malonate
1071-46-1

hydrogen ethyl malonate

3,4-dihydroxy-5-nitrobenzaldehyde
116313-85-0

3,4-dihydroxy-5-nitrobenzaldehyde

ethyl (E)-3-(3,4-dihydroxy-5-nitrophenyl)acrylate

ethyl (E)-3-(3,4-dihydroxy-5-nitrophenyl)acrylate

Conditions
ConditionsYield
With piperidine; pyridine at 60℃; for 24h; Knoevenagel Condensation;67.44%
neopentyl α-cyanoacetate
88107-40-8

neopentyl α-cyanoacetate

3,4-dihydroxy-5-nitrobenzaldehyde
116313-85-0

3,4-dihydroxy-5-nitrobenzaldehyde

Neopentyl 2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)acrylate

Neopentyl 2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)acrylate

Conditions
ConditionsYield
67%
1-cyanoacetylpiperidine
15029-30-8

1-cyanoacetylpiperidine

3,4-dihydroxy-5-nitrobenzaldehyde
116313-85-0

3,4-dihydroxy-5-nitrobenzaldehyde

(2E)-3-(3,4-dihydroxy-5-nitrophenyl)-2-(piperidin-yl-1-carbonyl)prop-2-ennitrile
1150310-15-8

(2E)-3-(3,4-dihydroxy-5-nitrophenyl)-2-(piperidin-yl-1-carbonyl)prop-2-ennitrile

Conditions
ConditionsYield
With piperidine; acetic acid In toluene Knoevenagel condensation; Reflux;67%
With ammonium acetate In methanol for 3h; Reflux;13%

116313-85-0Relevant articles and documents

Improved method for demethylation of nitro-catechol methyl ethers

Learmonth, David A.,Alves, Paula C.

, p. 641 - 649 (2002)

Several nitro-catechol compounds, useful as inhibitors of COMT were obtained in excellent yield and purity via an improved procedure for demethylation of the corresponding methyl ethers using aluminium chloride and pyridine in ethyl acetate.

The inhibition of catechol O-methyltransferase and monoamine oxidase by tetralone and indanone derivatives substituted with the nitrocatechol moiety

de Beer, Andries D.,Legoabe, Lesetja J.,Petzer, Anél,Petzer, Jacobus P.

, (2021)

The enzymes, catechol O-methyltransferase (COMT) and monoamine oxidase (MAO) are important drug targets, and inhibitors of these enzymes are established therapy for symptomatic Parkinson's disease (PD). COMT inhibitors enhance the bioavailability of levodopa to the brain, and therefore are combined with levodopa for the treatment of motor fluctuations in PD. Inhibitors of the MAO-B isoform, in turn, are used as monotherapy or in conjunction with levodopa in PD, and function by reducing the central degradation of dopamine. It has been reported that 1-tetralone and 1-indanone derivatives are potent and specific inhibitors of MAO-B, while compounds containing the nitrocatechol moiety (e.g. tolcapone and entacapone) are often potent COMT inhibitors. The present study attempted to discover compounds that exhibit dual COMT and MAO-B inhibition by synthesizing series of 1-tetralone, 1-indanone and related derivatives substituted with the nitrocatechol moiety. These compounds are structurally related to series of nitrocatechol derivatives of chalcone that have recently been investigated as potential dual COMT/MAO inhibitors. The results show that 4-chromanone derivative (7) is the most promising dual inhibitor with IC50 values of 0.57 and 7.26 μM for COMT and MAO-B, respectively, followed by 1-tetralone derivative (4d) with IC50 values of 0.42 and 7.83 μM for COMT and MAO-B, respectively. Based on their potent inhibition of COMT, it may be concluded that nitrocatechol compounds investigated in this study are appropriate for peripheral COMT inhibition, which represents an important strategy in the treatment of PD.

Method for producing entacapone

-

Paragraph 0050-0058, (2021/04/10)

The present invention relates to an entacapone production method, which comprises a nitration reaction, a de-methylation reaction and a condensation reaction. The nitration reaction is completed by glacial acetic acid, vanillin and 65% nitric acid within 3-5 hours; the de-methylation reaction is completed by reaction among nitrovanillin, dichloromethane, tetrabutyl ammonium bromide, anhydrous aluminum chloride and pyridine; and the condensation reaction is completed by reaction among isopropanol, 3,4-dihydroxyl-5-nitro benzaldehyde, N,N-diethyl cyanoacetamide and piperidine. The entacapone production method provided by the invention is high in yield, high in purity and stable in quality.

Pyridine Improves Aluminum Triiodide Induced Selective Cleavage of Alkyl o -Hydroxyphenyl Ethers: A Practical and Efficient Procedure for the Preparation of Hydroxychavicol by Demethylation of Eugenol

Sang, Dayong,Yao, Ming,Tian, Juan,Chen, Xiaoman,Li, Li,Zhan, Hongju,You, Linhong

, p. 138 - 142 (2016/12/26)

Demethylation of eugenol with aluminum triiodide is complicated by an unexpected hydrogenation side reaction. The hydrogenation proceeds through a cascade deprotonation, hydroiodination, and hydrogen-halogen exchange process, and can be prevented by suppressing the hydroiodination in advance. A practical demethylation procedure is thus developed that delivers hydryoxychavicol in essentially quantitative yield by using pyridine as an additive. The method is selective towards cleaving alkyl o-hydroxyphenyl ethers and is compatible with a variety of functional groups.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 116313-85-0